This is higher than the typical 20% to 25% lean mass loss seen with caloric restriction alone
A large-scale study has found that glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, used to treat obesity and diabetes, are also effective in reducing the worsening of depression and anxiety disorder symptoms
Inactivity is the killer and, remember, it's never too late." -Jack Lalanne In the first part of our series on weight loss and muscle mass , we concluded that the data, though incomplete, does not compellingly demonstrate excess muscle loss in patients who use GLP-1 medications as compared to other weight loss methods
Kesavan K, Kant S, Singh PN, Pandit JK
Simply add any 2 items to your cart
To view a copy of this licence, visit About this article Cite this article Ehsasatvatan, M., Baghban Kohnehrouz, B